Sandu Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

9.66

8.81

7.92

7.08

7.08

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

29.58

27.66

25.57

22.16

21.71

Loan funds

Secured loans

-

-

0.02

1.25

6.10

Unsecured loans

-

-

-

-

-

Total

39.24

36.47

33.51

30.48

34.89

Uses of funds

Fixed assets

Gross block

26.17

25.20

15.38

25.66

25.58

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

9.55

9.20

8.85

9.06

8.54

Net block

16.62

16.00

6.53

16.60

17.04

Capital work-in-progress

0.42

0.48

-

-

-

Investments

9.66

9.11

0.24

0.82

1.13

Net current assets

Current assets, loans & advances

27.47

23.69

40.19

23.99

25.47

Less : current liabilities & provisions

14.92

12.81

13.45

10.93

8.74

Total net current assets

12.55

10.88

26.73

13.05

16.72

Miscellaneous expenses not written

-

-

-

-

-

Total

39.24

36.47

33.51

30.48

34.89

Notes:

Book value of unquoted investments

0.01

-

-

0.82

-

Market value of quoted investments

9.65

9.11

0.24

-

-

Contingent liabilities

-

-

2.83

2.83

-

Number of equity sharesoutstanding (Lacs)

96.61

88.11

79.21

70.81

70.81